X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3056) 3056
Publication (238) 238
Book Chapter (38) 38
Book Review (36) 36
Dissertation (16) 16
Conference Proceeding (7) 7
Web Resource (3) 3
Paper (2) 2
Trade Publication Article (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1762) 1762
index medicus (1605) 1605
bloodstream infection (1346) 1346
infectious diseases (1193) 1193
male (1037) 1037
female (1003) 1003
bacteremia (785) 785
middle aged (734) 734
bloodstream infections (704) 704
microbiology (686) 686
mortality (671) 671
aged (653) 653
risk factors (644) 644
adult (629) 629
health aspects (570) 570
epidemiology (515) 515
bacteremia - microbiology (498) 498
sepsis (460) 460
infections (439) 439
nosocomial infections (436) 436
retrospective studies (413) 413
prevention (404) 404
bacteremia - epidemiology (387) 387
risk-factors (341) 341
aged, 80 and over (335) 335
surveillance (330) 330
hospitals (328) 328
infectious disease (323) 323
adolescent (319) 319
blood-stream infections (314) 314
catheterization, central venous - adverse effects (308) 308
catheter-related bloodstream infection (305) 305
prospective studies (299) 299
cross infection - epidemiology (296) 296
anti-bacterial agents - therapeutic use (293) 293
incidence (290) 290
child (283) 283
research (274) 274
analysis (272) 272
diagnosis (260) 260
pediatrics (255) 255
central venous catheter (253) 253
blood (251) 251
immunology (250) 250
infant (250) 250
antibiotics (248) 248
child, preschool (246) 246
bacteremia - drug therapy (240) 240
infant, newborn (240) 240
infection (233) 233
young adult (232) 232
central venous catheters (230) 230
cross infection (225) 225
medicine (225) 225
catheter-related infections - prevention & control (224) 224
cross infection - microbiology (218) 218
infection control (218) 218
catheter-related infections - epidemiology (217) 217
catheters (217) 217
microbial sensitivity tests (217) 217
pharmacology & pharmacy (215) 215
bacteria (214) 214
public, environmental & occupational health (213) 213
treatment outcome (212) 212
staphylococcus aureus (207) 207
intensive care units (202) 202
impact (201) 201
cross infection - prevention & control (195) 195
research article (195) 195
patients (194) 194
intensive-care-unit (189) 189
bacteremia - mortality (183) 183
care and treatment (181) 181
hematology (181) 181
management (179) 179
therapy (179) 179
children (178) 178
drug resistance (171) 171
bacteremia - etiology (169) 169
intensive care (168) 168
cohort studies (166) 166
medical research (163) 163
bacteremia - diagnosis (161) 161
anti-bacterial agents - pharmacology (159) 159
internal medicine (158) 158
bacteremia - prevention & control (157) 157
antimicrobial resistance (156) 156
blood culture (155) 155
guidelines (155) 155
critical care medicine (154) 154
pneumonia (152) 152
central line-associated bloodstream infection (149) 149
complications (149) 149
outcomes (148) 148
cancer (147) 147
drug resistance in microorganisms (147) 147
resistance (147) 147
risk (147) 147
prevalence (146) 146
critically-ill patients (145) 145
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2910) 2910
Spanish (52) 52
French (35) 35
Japanese (31) 31
German (28) 28
Chinese (14) 14
Portuguese (12) 12
Korean (10) 10
Turkish (7) 7
Russian (5) 5
Polish (4) 4
Italian (3) 3
Czech (2) 2
Croatian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


AJIC: American Journal of Infection Control, ISSN 0196-6553, 2012, Volume 40, Issue 5, pp. 396 - 407
The results of a surveillance study conducted by the International Nosocomial Infection Control Consortium (INICC) from January 2004 through December 2009 in... 
Infectious Disease | Infection Control | Nosocomial infection | Ventilator-associated pneumonia | Low-income countries | Bloodstream infection | Developing countries | Central line-associated bloodstream infection | Limited-resources countries | Health care-associated infection | Urinary tract infection | Catheter-associated urinary tract infection | Network | Antibiotic resistance | Hospital infection | Device-associated infection | MORTALITY | INTENSIVE-CARE UNITS | CONTROL PROGRAM | RATES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PERFORMANCE FEEDBACK | SAFETY NETWORK | INFECTIOUS DISEASES | LENGTH-OF-STAY | ARGENTINEAN HOSPITALS | BLOOD-STREAM INFECTIONS | Africa - epidemiology | Prevalence | Prospective Studies | Humans | Middle Aged | Cross Infection - mortality | Child, Preschool | Infant | Male | Young Adult | Aged, 80 and over | Bacteria - classification | Adult | Female | Child | Infant, Newborn | Cross Infection - epidemiology | Latin America - epidemiology | Intensive Care Units | Europe - epidemiology | International Cooperation | Asia - epidemiology | Bacteria - isolation & purification | Adolescent | Bacterial Infections - epidemiology | Aged | Bacterial Infections - mortality | Consortia | Medical colleges | Pneumonia | Hotels and motels | Bacterial pneumonia | Staphylococcus aureus infections | Urinary tract infections | Health aspects | Antibacterial agents | Public health | Infection control | Bacteria | Intensive care | Bacterial infections | Nosocomial infections | Mortality
Journal Article
Journal of Infection, ISSN 0163-4453, 2014, Volume 69, Issue 3, pp. 216 - 225
Summary Background An intervention for Gram-negative bloodstream infections that integrated mass spectrometry technology for rapid diagnosis with antimicrobial... 
Infectious Disease | Bloodstream infections | Multidrug resistant | Antimicrobial stewardship | MALDI-TOF | Rapid diagnostics | MORTALITY | ACQUIRED INFECTIONS | INFECTIOUS DISEASES | METAANALYSIS | IDENTIFICATION | DISEASES SOCIETY | IMPACT | THERAPY | HEALTH-CARE | BLOOD-STREAM INFECTIONS | ENTEROBACTERIACEAE | Humans | Middle Aged | Bacteremia - mortality | Male | Pseudomonas Infections - mortality | Gram-Negative Bacterial Infections - microbiology | Time Factors | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Time-to-Treatment | Bacteremia - drug therapy | Klebsiella - enzymology | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas Infections - diagnosis | Survival Rate | Pseudomonas Infections - microbiology | Klebsiella Infections - diagnosis | Gram-Negative Bacterial Infections - diagnosis | Hospital Costs | Escherichia coli Infections - mortality | Pseudomonas aeruginosa - isolation & purification | beta-Lactam Resistance | Acinetobacter Infections - mortality | Klebsiella - isolation & purification | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Adult | Female | beta-Lactamases - metabolism | Acinetobacter Infections - microbiology | Length of Stay | Escherichia coli Infections - diagnosis | Intensive Care Units | Klebsiella Infections - drug therapy | Acinetobacter Infections - diagnosis | Hospital Mortality | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Treatment Outcome | Bacteremia - diagnosis | Klebsiella Infections - microbiology | Escherichia coli - isolation & purification | Klebsiella Infections - mortality | Aged | Gram-Negative Bacterial Infections - mortality | Drug resistance in microorganisms | Care and treatment | Mass spectrometry | Patient outcomes
Journal Article
AJIC: American Journal of Infection Control, ISSN 0196-6553, 2014, Volume 42, Issue 9, pp. 942 - 956
Journal Article
AJIC: American Journal of Infection Control, ISSN 0196-6553, 2010, Volume 38, Issue 2, pp. 95 - 104.e2
Journal Article
Journal Article
AJIC: American Journal of Infection Control, ISSN 0196-6553, 2015, Volume 44, Issue 4, pp. 444 - 449
Background To report the results of the International Infection Control Consortium (INICC) study conducted in Kuwait from November 2013-March 2015. Methods A... 
Infectious Disease | Infection Control | health care–associated infection | antibiotic resistance | catheter-associated urinary tract infection | Hospital infection | central line–associated bloodstream infections | ventilator-associated pneumonia | bloodstream infection | nosocomial infection | urinary tract infection | network | INFECTIOUS DISEASES | central line associated bloodstream infections | STRATEGY | nosocornial infection | INTENSIVE-CARE UNITS | MULTIDIMENSIONAL APPROACH | IMPACT | MODULE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | catheter associated urinary tract infection | INICC REPORT | health care-associated infection | DEVELOPING-COUNTRIES | Pneumonia, Ventilator-Associated - mortality | Prevalence | Prospective Studies | Humans | Middle Aged | Bacteria - drug effects | Child, Preschool | Drug Resistance, Bacterial | Infant | Male | Pneumonia, Ventilator-Associated - epidemiology | Aged, 80 and over | Bacteria - classification | Catheter-Related Infections - mortality | Adult | Female | Catheter-Related Infections - epidemiology | Child | Infant, Newborn | Length of Stay | Bacteria - isolation & purification | Kuwait - epidemiology | Adolescent | Bacterial Infections - epidemiology | Survival Analysis | Aged | Bacterial Infections - mortality | Medicine, Experimental | Medical research | Drug resistance | Health aspects | Mortality | Medical equipment | Bacterial infections | Nosocomial infections
Journal Article
European Journal of Clinical Microbiology & Infectious Diseases, ISSN 0934-9723, 9/2018, Volume 37, Issue 9, pp. 1627 - 1636
The proportion of antimicrobial resistance (AMR) among the ESKAPE and Escherichia coli (ESKAPEEc) pathogens causing bloodstream infection (BSI) increased... 
Medical Microbiology | Biomedicine | Targeted therapy | Escherichia coli | Bloodstream infections | Internal Medicine | ESKAPE | Antimicrobial resistance | MORTALITY | INFECTIOUS DISEASES | MULTICENTER | MICROBIOLOGY | THERAPY | PREDICTORS | DISSEMINATION | ENTEROBACTERIACEAE | PATHOGENS | Escherichia coli - drug effects | Humans | Escherichia coli Infections - blood | Molecular Targeted Therapy | Incidence | Bacteremia - microbiology | Hospitals, Teaching - statistics & numerical data | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Drug Resistance, Multiple, Bacterial | Staphylococcal Infections - microbiology | Catheter-Related Infections - epidemiology | Cross Infection - epidemiology | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Bacteremia - drug therapy | Escherichia coli Infections - microbiology | beta-Lactamases - drug effects | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Cross Infection - drug therapy | Catheter-Related Infections - drug therapy | Bacterial Proteins - drug effects | Escherichia coli Infections - epidemiology | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Catheter-Related Infections - microbiology | Cross Infection - microbiology | Bacteremia - epidemiology | Anti-Bacterial Agents - pharmacology | Drug resistance in microorganisms | Pneumonia | Bacterial pneumonia | Beta lactamases | Health aspects | Public health | Klebsiella | Health care | Pathogens | Communities | Carbapenemase | Antimicrobial agents | Infections | Drug resistance | Antiinfectives and antibacterials | Methicillin | E coli | Pseudomonas aeruginosa | Bacteria | Meropenem | Trends | Ciprofloxacin | Active control | Emergency medical services | Ceftazidime
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2012, Volume 7, Issue 5, p. e37281
Formation of resilient biofilms on medical devices colonized by pathogenic microorganisms is a major cause of health-care associated infection. While in vitro... 
ANTIBIOTIC-LOCK TECHNIQUE | CONTROLLED-TRIAL | DIAGNOSIS | THERAPY | BACTEREMIA | IN-VIVO | BIOLOGY | ACCESS SYSTEM | MICE | CANCER | BLOOD-STREAM INFECTIONS | Staphylococcal Infections - drug therapy | Cefazolin - therapeutic use | Gentamicins - therapeutic use | Biofilms - growth & development | Pseudomonas Infections - complications | Rats | Male | Equipment Contamination | Staphylococcal Infections - complications | Anti-Bacterial Agents - therapeutic use | Animals | Staphylococcus epidermidis | Immunosuppression - adverse effects | Catheters, Indwelling - adverse effects | Models, Animal | Pseudomonas aeruginosa | Catheterization, Central Venous - adverse effects | Escherichia coli Infections - complications | Medical research | Medical equipment | Bacterial infections | Escherichia coli | Staphylococcus aureus infections | Medicine, Experimental | Cross infection | Nosocomial infections | Health aspects | Physiological apparatus | Staphylococcus aureus | Pediatrics | Surgical implants | Bioluminescence | Medical innovations | Disseminated infection | Clinical trials | Infections | Microorganisms | E coli | Bacteria | Pathogens | Medical devices | Stability | Complications | Medical instruments | Staphylococcus infections | Disease control | Contamination | Catheters | Biofilms | Antibiotics | Colonization | Cefazolin/therapeutic use | Escherichia coli infections | Biofilms/growth & development | Central Venous/adverse effects | Life Sciences | Staphylococcal Infections/complications/drug therapy | Pseudomonas Infections/complications | Bloodstream infections | Immunosuppression/adverse effects | Bacterial biofilms | Gentamicins/therapeutic use | Catheterization | Indwelling/adverse effects | Escherichia coli Infections/complications | bacterial pathogens | Bacteriology | Microbiology and Parasitology | Animal | Models | Anti-Bacterial Agents/therapeutic use
Journal Article